Becker’s Hospital Review
Buyer Beware: DOJ Pursuing Private Equity Investors in Healthcare
December 20, 2018
As many in the healthcare industry have come to appreciate, the Civil War-era False Claims Act (“FCA”) is an exceptionally broad statute that has been the Department of Justice’s (“DOJ”) primary lever over the last twenty years in extracting billions of dollars of recoveries from healthcare providers accused of conduct ranging from clear fraud to regulatory infractions.
View the complete article on the Becker's Hospital Review website.
Contacts
Related Blogs
Capabilities
Suggested News & Insights
BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 11, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025Sidley Represents Lumexa Imaging in US$462.5 Million Initial Public OfferingDecember 10, 2025First Circuit Clarifies Application of Medicare’s “Reasonable and Necessary” Standard in FCA Cases Against Clinical LabsDecember 8, 2025Medicare Payment Policy Final Rule for Outpatient Setting Addresses Radiopharmaceuticals, Skin Substitutes, and 340B Program Key TopicsDecember 2, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
